Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 8120405)

1.

Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor.

Mullarkey MF, Leiferman KM, Peters MS, Caro I, Roux ER, Hanna RK, Rubin AS, Jacobs CA.

J Immunol. 1994 Feb 15;152(4):2033-41.

PMID:
8120405
2.
3.

Phase I/II trial of the type I soluble recombinant human interleukin-1 receptor in HIV-1-infected patients.

Takebe N, Paredes J, Pino MC, Lownsbury WH, Agosti J, Krown SE.

J Interferon Cytokine Res. 1998 May;18(5):321-6.

PMID:
9620359
4.

Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin.

Phipps S, Flood-Page P, Menzies-Gow A, Ong YE, Kay AB.

J Invest Dermatol. 2004 Jun;122(6):1406-12.

8.

A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia.

Bernstein SH, Fay J, Frankel S, Christiansen N, Baer MR, Jacobs C, Blosch C, Hanna R, Herzig G.

Cancer Chemother Pharmacol. 1999;43(2):141-4.

PMID:
9923819
9.

Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.

Charlesworth EN, Kagey-Sobotka A, Schleimer RP, Norman PS, Lichtenstein LM.

J Immunol. 1991 Jan 15;146(2):671-6.

PMID:
1702812
11.
12.
13.

Allergen dose dependency of the early- and late-phase cutaneous response in the cynomolgus monkey.

Tomkinson A, Morton M, Stevens L, Bowden A, Tepper J.

Clin Exp Allergy. 2009 Jul;39(7):1080-7. doi: 10.1111/j.1365-2222.2009.03240.x. Epub 2009 Apr 7.

PMID:
19400909
14.

Products of arachidonic acid metabolism and the effects of cyclooxygenase inhibition on ongoing cutaneous allergic reactions in human beings.

Atkins PC, Zweiman B, Littman B, Presti C, von Allmen C, Moskovitz A, Eskra JD.

J Allergy Clin Immunol. 1995 Mar;95(3):742-7.

PMID:
7897158
17.
18.

Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.

Gosset P, Tillie-Leblond I, Malaquin F, Durieu J, Wallaert B, Tonnel AB.

Clin Exp Allergy. 1997 Apr;27(4):379-88.

PMID:
9146930
19.

Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema.

Langeveld-Wildschut EG, Thepen T, Bihari IC, ven Reijsen FC, de Vries IJ, Bruijnzeel PL, Bruijnzeel-Koomen CA.

J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1019-27.

PMID:
8977500
20.

Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects.

Corrigan CJ, Jayaratnam A, Wang Y, Liu Y, de Waal Malefyt R, Meng Q, Kay AB, Phipps S, Lee TH, Ying S.

Allergy. 2009 Jul;64(7):1014-22. doi: 10.1111/j.1398-9995.2009.01947.x. Epub 2009 Feb 2.

PMID:
19187393
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk